Oslo, Norway 8 May 2019 - The shareholders of PCI Biotech Holding ASA are invited to attend the Annual General Meeting 2019 at Oslo Cancer Cluster Innovation Park.
Time: Wednesday May 29, 10am CEST (local time).
Venue: Jónas Einarsson Auditorium (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo, Norway.
The notice including attendance, proxy and advance voting forms will be mailed to all shareholders with known address. The complete notice, including executive remuneration statement and the recommendation from the Nomination Committee, is attached to this notification and will also be available at PCI Biotech's corporate website www.pcibiotech.com.
For further information, please contact:
Ronny Skuggedal, CFO, E-mail: rs@pcibiotech.no
Office: +47 67 11 54 00 Mobile: +47 94 00 57 57
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
Attachments
- PCI Biotech Notice AGM 2019 (https://ml-eu.globenewswire.com/Resource/Download/99ff5fbb-423d-4939-93a4-e0a72351a645)
- PCI Biotech Executive remuneration statement 2019 (https://ml-eu.globenewswire.com/Resource/Download/275ae393-76c2-407a-9778-318d96b9039c)
- PCI Biotech Proposal from the Nomination Committee 2019 (https://ml-eu.globenewswire.com/Resource/Download/afbd1a5a-e035-4010-9826-cd47916a0299)
